Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2309 ARTÍCULOS , VIENDO DEL 1666 AL 1680

The FDA-approved anti-amyloid-β monoclonal antibodies for the treatment of Alzheimer's disease: a systematic review and meta-analysis of randomized controlled trials

Wu W, Ji Y, Wang Z, Wu X, Li J, Gu F, Chen Z, Wang Z.

Eur J Med Res. 2023 Nov 28;28(1):544. doi: 10.1186/s40001-023-01512-w.

Validating blood tests as a possible routine diagnostic assay of Alzheimer's disease

Kodosaki E, Zetterberg H, Heslegrave A.

Expert Rev Mol Diagn. 2023 Jul-Dec;23(12):1153-1165. doi: 10.1080/14737159.2023.2289553. Epub 2023 Dec 15.

Cerebrospinal and Blood Biomarkers in Alzheimer's Disease: Did Mild Cognitive Impairment Definition Affect Their Clinical Usefulness?

Bivona G, Iemmolo M, Ghersi G.

Int J Mol Sci. 2023 Nov 29;24(23):16908. doi: 10.3390/ijms242316908.

Longitudinal cerebrospinal fluid measurements show glial hypo- and hyperactivation in predementia Alzheimer's disease

Nordengen K, Kirsebom BE, Richter G, Pålhaugen L, Gísladóttir B, Siafarikas N, Nakling A, Rongve A, Bråthen G, Grøntvedt GR, Gonzalez F, Waterloo K, Sharma K, Karikari T, Vromen EM, Tijms BM, Visser PJ, Selnes P, Kramberger MG, Winblad B, Blennow K, Fladby T.

J Neuroinflammation. 2023 Dec 13;20(1):298. doi: 10.1186/s12974-023-02973-w.

Blood Neurofilament Levels Predict Cognitive Decline across the Alzheimer's Disease Continuum

Lehmann S, Schraen-Maschke S, Vidal JS, Blanc F, Paquet C, Allinquant B, Bombois S, Gabelle A, Delaby C, Hanon O; BALTAZAR Study Group.

Int J Mol Sci. 2023 Dec 11;24(24):17361. doi: 10.3390/ijms242417361.

Biological Diagnosis of Alzheimer's Disease Based on Amyloid Status: An Illustration of Confirmation Bias in Medical Research?

Souchet B, Michaïl A, Billoir B, Braudeau J.

Int J Mol Sci. 2023 Dec 16;24(24):17544. doi: 10.3390/ijms242417544.

The Role of CSF Transthyretin in Human Alzheimer's Disease: Offense, Defense, or not so Innocent Bystander

Buxbaum JN.

J Integr Neurosci. 2023 Nov 6;22(6):158. doi: 10.31083/j.jin2206158.

Protein misfolding, ER stress and chaperones: an approach to develop chaperone-based therapeutics for Alzheimer's disease

Singh R, Kaur N, Dhingra N, Kaur T.

Int J Neurosci. 2023 Jul;133(7):714-734. doi: 10.1080/00207454.2021.1968859. Epub 2022 May 21.

Using second life to teach health professions students about Alzheimer's Disease: A comprehensive review

Barros Una L, Brangman S, Indelicato A, Krueger A, Ludwig A, Slutzky AR, Stewart T, Germain LJ.

Gerontol Geriatr Educ. 2023 Apr-Jun;44(2):243-253. doi: 10.1080/02701960.2021.2022660. Epub 2022 Jan 7.

Lipid metabolism and Alzheimer's disease: clinical evidence, mechanistic link and therapeutic promise

Yin F.

FEBS J. 2023 Mar;290(6):1420-1453. doi: 10.1111/febs.16344. Epub 2022 Jan 18.

The Role of ERK1/2 Pathway in the Pathophysiology of Alzheimer's Disease: An Overview and Update on New Developments

Khezri MR, Yousefi K, Esmaeili A, Ghasemnejad-Berenji M.

Cell Mol Neurobiol. 2023 Jan;43(1):177-191. doi: 10.1007/s10571-022-01191-x. Epub 2022 Jan 17.

Recent Insights on Glutamatergic Dysfunction in Alzheimer's Disease and Therapeutic Implications

Pinky PD, Pfitzer JC, Senfeld J, Hong H, Bhattacharya S, Suppiramaniam V, Qureshi I, Reed MN.

Neuroscientist. 2023 Aug;29(4):461-471. doi: 10.1177/10738584211069897. Epub 2022 Jan 25.

Effectiveness of physical exercise at improving functional capacity in older adults living with Alzheimer's disease: a systematic review of randomized controlled trials

Braz de Oliveira MP, Moreira Padovez RFC, Serrão PRMDS, de Noronha MA, Cezar NOC, Andrade LP.

Disabil Rehabil. 2023 Feb;45(3):391-402. doi: 10.1080/09638288.2022.2037744. Epub 2022 Feb 16.

Improving Brain Health for Populations Disproportionately Affected by Alzheimer's Disease and Related Dementias

Olivari BS, Jeffers EM, Tang KW, McGuire LC.

Clin Gerontol. 2023 Mar-Apr;46(2):128-132. doi: 10.1080/07317115.2022.2043977. Epub 2022 Mar 2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias